{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T11:58:46Z","timestamp":1768478326345,"version":"3.49.0"},"reference-count":47,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Daiichi Sankyo S.p.A."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Identifying and treating lipid abnormalities is crucial for preventing cardiovascular disease in diabetic patients, yet only two-thirds of patients reach recommended cholesterol levels. Elucidating the factors associated with lipid goal attainment represents an unmet clinical need. To address this knowledge gap, we conducted a real-world analysis of the lipid profiles of 11.252 patients from the Annals of the Italian Association of Medical Diabetologists (AMD) database from 2005 to 2019. We used a Logic Learning Machine (LLM) to extract and classify the most relevant variables predicting the achievement of a low-density lipoprotein cholesterol (LDL-C) value lower than 100 mg\/dL (2.60 mmol\/L) within two years of the start of lipid-lowering therapy. Our analysis showed that 61.4% of the patients achieved the treatment goal. The LLM model demonstrated good predictive performance, with a precision of 0.78, accuracy of 0.69, recall of 0.70, F1 Score of 0.74, and ROC-AUC of 0.79. The most significant predictors of achieving the treatment goal were LDL-C values at the start of lipid-lowering therapy and their reduction after six months. Other predictors of a greater likelihood of reaching the target included high-density lipoprotein cholesterol, albuminuria, and body mass index at baseline, as well as younger age, male sex, more follow-up visits, no therapy discontinuation, higher Q-score, lower blood glucose and HbA1c levels, and the use of anti-hypertensive medication. At baseline, for each LDL-C range analysed, the LLM model also provided the minimum reduction that needs to be achieved by the next six-month visit to increase the likelihood of reaching the therapeutic goal within two years. These findings could serve as a useful tool to inform therapeutic decisions and to encourage further in-depth analysis and testing.<\/jats:p>","DOI":"10.3390\/jcm12124095","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T08:56:01Z","timestamp":1686905761000},"page":"4095","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Uncovering Predictors of Lipid Goal Attainment in Type 2 Diabetes Outpatients Using Logic Learning Machine: Insights from the AMD Annals and AMD Artificial Intelligence Study Group"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0820-633X","authenticated-orcid":false,"given":"Davide","family":"Masi","sequence":"first","affiliation":[{"name":"Department of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinology, Sapienza University of Rome, 00161 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Zilich","sequence":"additional","affiliation":[{"name":"Mix-x SRL, 10015 Ivrea, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Candido","sequence":"additional","affiliation":[{"name":"Associazione Medici Diabetologi, Giuliano Isontina University Health Service, 34149 Trieste, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Giancaterini","sequence":"additional","affiliation":[{"name":"UOSD Diabetology, Department of Exchange and Nutrition Diseases, Brianza Health Service, Pio XI Hospital, 20833 Desio, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Guaita","sequence":"additional","affiliation":[{"name":"Diabetes and Endocrinology Unit, ASL SULCIS, 9016 Iglesias, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9999-2331","authenticated-orcid":false,"given":"Marco","family":"Muselli","sequence":"additional","affiliation":[{"name":"Rulex Innovation Labs, Rulex Inc., 16122 Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Ponzani","sequence":"additional","affiliation":[{"name":"Diabetes and Metabolic Disease Unit, ASL 4 Liguria, 16043 Chiavari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierluigi","family":"Santin","sequence":"additional","affiliation":[{"name":"Deimos, 33100 Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damiano","family":"Verda","sequence":"additional","affiliation":[{"name":"Rulex Innovation Labs, Rulex Inc., 16122 Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9530-2869","authenticated-orcid":false,"given":"Nicoletta","family":"Musacchio","sequence":"additional","affiliation":[{"name":"Associazione Medici Diabetologi, 20156 Milano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,16]]},"reference":[{"key":"ref_1","first-page":"1","article-title":"Cardiovascular Risk in Diabetes Mellitus: Epidemiology, Assessment and Prevention","volume":"1","author":"Wong","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-021-05585-2","article-title":"Interpreting Global Trends in Type 2 Diabetes Complications and Mortality","volume":"65","author":"Ali","year":"2022","journal-title":"Diabetologia"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.metabol.2014.08.010","article-title":"Diabetic Dyslipidemia","volume":"63","author":"Wu","year":"2014","journal-title":"Metabolism"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1001\/archinternmed.2009.296","article-title":"Trends in Medication Use Among US Adults with Diabetes Mellitus: Glycemic Control at the Expense of Controlling Cardiovascular Risk Factors","volume":"169","author":"Mann","year":"2009","journal-title":"Arch. Intern Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.phrs.2018.12.002","article-title":"Characteristics of Lipid Profile and Effectiveness of Management of Dyslipidaemia in Patients with Acute Coronary Syndromes\u2013Data from the TERCET Registry with 19,287 Patients","volume":"139","author":"Dyrbus","year":"2019","journal-title":"Pharmacol. Res."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Villegas, R., Kearney, P.M., and Perry, I.J. (2008). The Cumulative Effect of Core Lifestyle Behaviours on the Prevalence of Hypertension and Dyslipidemia. BMC Public Health, 8.","DOI":"10.1186\/1471-2458-8-210"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"(2010). Cholesterol Treatment Trialists\u2019 (CTT) Collaboration Efficacy and Safety of More Intensive Lowering of LDL Cholesterol: A Meta-Analysis of Data from 170,000 Participants in 26 Randomised Trials. Lancet, 376, 1670\u20131681.","DOI":"10.1016\/S0140-6736(10)61350-5"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"(2010). American Diabetes Association Standards of Medical Care in Diabetes\u20142010. Diabetes Care, 33, S11\u2013S61.","DOI":"10.2337\/dc10-S011"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/1753-0407.12524","article-title":"American Diabetes Association Standards of Medical Care in Diabetes 2017","volume":"9","author":"Marathe","year":"2017","journal-title":"J. Diabetes"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.2337\/dc23-Sint","article-title":"Introduction and Methodology: Standards of Care in Diabetes\u20142023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on Cardiovascular Disease Prevention in Clinical Practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12933-021-01251-4","article-title":"Clinical Profiles and Quality of Care of Subjects with Type 2 Diabetes According to Their Cardiovascular Risk: An Observational, Retrospective Study","volume":"20","author":"Pintaudi","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1038\/ncomms6068","article-title":"Pharmacogenetic Meta-Analysis of Genome-Wide Association Studies of LDL Cholesterol Response to Statins","volume":"5","author":"Postmus","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00228-015-1994-9","article-title":"Non-Response to (Statin) Therapy: The Importance of Distinguishing Non-Responders from Non-Adherers in Pharmacogenetic Studies","volume":"72","author":"Trompet","year":"2016","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.medj.2022.04.007","article-title":"Heterogeneity in Statin Responses Explained by Variation in the Human Gut Microbiome","volume":"3","author":"Wilmanski","year":"2022","journal-title":"Med"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"107505","DOI":"10.1016\/j.compbiolchem.2021.107505","article-title":"Drug Repurposing for Hyperlipidemia Associated Disorders: An Integrative Network Biology and Machine Learning Approach","volume":"92","author":"Rai","year":"2021","journal-title":"Comput. Biol. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"9973","DOI":"10.1038\/s41598-020-66199-z","article-title":"Adipose Tissue Morphology, Imaging and Metabolomics Predicting Cardiometabolic Risk and Family History of Type 2 Diabetes in Non-Obese Men","volume":"10","author":"Rawshani","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1464-5491.2010.03055.x","article-title":"Four-Year Impact of a Continuous Quality Improvement Effort Implemented by a Network of Diabetes Outpatient Clinics: The AMD-Annals Initiative: Quality Initiative in Diabetes Care","volume":"27","author":"Nicolucci","year":"2010","journal-title":"Diabet. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00592-014-0688-6","article-title":"Trends over 8 Years in Quality of Diabetes Care: Results of the AMD Annals Continuous Quality Improvement Initiative","volume":"52","author":"Rossi","year":"2015","journal-title":"Acta Diabetol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Masi, D., Risi, R., Biagi, F., Vasquez Barahona, D., Watanabe, M., Zilich, R., Gabrielli, G., Santin, P., Mariani, S., and Lubrano, C. (2022). Application of a Machine Learning Technology in the Definition of Metabolically Healthy and Unhealthy Status: A Retrospective Study of 2567 Subjects Suffering from Obesity with or without Metabolic Syndrome. Nutrients, 14.","DOI":"10.3390\/nu14020373"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e16922","DOI":"10.2196\/16922","article-title":"Artificial Intelligence and Big Data in Diabetes Care: A Position Statement of the Italian Association of Medical Diabetologists","volume":"22","author":"Musacchio","year":"2020","journal-title":"J. Med. Internet Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.numecd.2006.04.009","article-title":"Quality of Diabetes Care Predicts the Development of Cardiovascular Events: Results of the QuED Study","volume":"18","author":"Pellegrini","year":"2008","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2337\/dc10-1709","article-title":"Quality of Diabetes Care Predicts the Development of Cardiovascular Events: Results of the AMD-QUASAR Study","volume":"34","author":"Rossi","year":"2011","journal-title":"Diabetes Care"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jacc.2004.07.001","article-title":"Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines","volume":"44","author":"Grundy","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_26","first-page":"e596","article-title":"2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e001362","DOI":"10.1136\/bmjdrc-2020-001362","article-title":"Determinants of Good Metabolic Control without Weight Gain in Type 2 Diabetes Management: A Machine Learning Analysis","volume":"8","author":"Giorda","year":"2020","journal-title":"BMJ Open Diab. Res. Care"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Verda, D., Parodi, S., Ferrari, E., and Muselli, M. (2019). Analyzing Gene Expression Data for Pediatric and Adult Cancer Diagnosis Using Logic Learning Machine and Standard Supervised Methods. BMC Bioinform., 20.","DOI":"10.1186\/s12859-019-2953-8"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Alghamdi, N.A., and Al-Baity, H.H. (2022). Augmented Analytics Driven by AI: A Digital Transformation beyond Business Intelligence. Sensors, 22.","DOI":"10.3390\/s22208071"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"100485","DOI":"10.1016\/j.xcrm.2021.100485","article-title":"The Inclusion of Augmented Intelligence in Medicine: A Framework for Successful Implementation","volume":"3","author":"Bazoukis","year":"2022","journal-title":"Cell Rep. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/1753-0407.13361","article-title":"Transparent Machine Learning Suggests a Key Driver in the Decision to Start Insulin Therapy in Individuals with Type 2 Diabetes","volume":"15","author":"Musacchio","year":"2023","journal-title":"J. Diabetes"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5979","DOI":"10.1038\/s41598-022-09954-8","article-title":"On Evaluation Metrics for Medical Applications of Artificial Intelligence","volume":"12","author":"Hicks","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1016\/S2589-7500(20)30018-2","article-title":"Dynamic and Explainable Machine Learning Prediction of Mortality in Patients in the Intensive Care Unit: A Retrospective Study of High-Frequency Data in Electronic Patient Records","volume":"2","author":"Nielsen","year":"2020","journal-title":"Lancet Digit. Health"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.whi.2014.09.004","article-title":"Understanding Disparities in Lipid Management Among Patients with Type 2 Diabetes: Gender Differences in Medication Nonadherence after Treatment Intensification","volume":"25","author":"Billimek","year":"2015","journal-title":"Women\u2019s Health Issues"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/MJT.0b013e31824c3e8c","article-title":"Time Trends of Gender-Based Differences in Lipid Goal Attainments During Secondary Prevention of Coronary Artery Disease: Results of a 5-Year Survey","volume":"20","author":"Singh","year":"2013","journal-title":"Am. J. Ther."},{"key":"ref_36","first-page":"e506","article-title":"Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement from the American Heart Association","volume":"142","author":"Aggarwal","year":"2020","journal-title":"Circulation"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.amjcard.2022.11.039","article-title":"Post\u2013Acute Coronary Syndrome Disparities in Guideline-Directed Lipid Therapy and Insufficient Achievement of Optimal Low-Density Lipoprotein","volume":"190","author":"Ambrosino","year":"2023","journal-title":"Am. J. Cardiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4093\/dmj.2015.39.5.353","article-title":"Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia","volume":"39","author":"Parhofer","year":"2015","journal-title":"Diabetes Metab. J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"133","DOI":"10.7326\/0003-4819-122-2-199501150-00010","article-title":"Effects of Antihypertensive Therapy on Serum Lipids","volume":"122","author":"Kasiske","year":"1995","journal-title":"Ann. Intern Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.1996.03530440029033","article-title":"Long-Term Effects on Plasma Lipids of Diet and Drugs to Treat Hypertension","volume":"275","author":"Grimm","year":"1996","journal-title":"JAMA"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1161\/01.cir.0000436752.99896.22","article-title":"Secondary Prevention of Atherosclerotic Cardiovascular Disease in Older Adults: A Scientific Statement from the American Heart Association","volume":"128","author":"Fleg","year":"2013","journal-title":"Circulation"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e722","DOI":"10.1161\/CIR.0000000000001040","article-title":"Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association","volume":"145","author":"Joseph","year":"2022","journal-title":"Circulation"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"436","DOI":"10.5551\/jat.5405","article-title":"Molecular Mechanisms of HDL-Cholesterol Elevation by Statins and Its Effects on HDL Functions","volume":"17","author":"Yamashita","year":"2010","journal-title":"JAT"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"164","DOI":"10.7555\/JBR.31.20160103","article-title":"The Pleiotropic Vasoprotective Functions of High Density Lipoproteins (HDL)","volume":"32","author":"Guilaine","year":"2018","journal-title":"J. Biomed. Res."},{"key":"ref_45","first-page":"41","article-title":"The Impact of Obesity on the Efficacy of Simvastatin for Lowering Low-Density Lipoprotein Cholesterol in a Veteran Population","volume":"34","author":"Sharpton","year":"2017","journal-title":"Fed. Pract."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12944-016-0350-0","article-title":"Efficacy of Statins in Patients with Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled Trials","volume":"15","author":"Shen","year":"2016","journal-title":"Lipids Health Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2217\/pgs.13.35","article-title":"Genome-Wide Studies in Pharmacogenomics: Harnessing the Power of Extreme Phenotypes","volume":"14","author":"Gurwitz","year":"2013","journal-title":"Pharmacogenomics"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/12\/4095\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:56:36Z","timestamp":1760126196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/12\/4095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":47,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["jcm12124095"],"URL":"https:\/\/doi.org\/10.3390\/jcm12124095","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,16]]}}}